ReBio Technologies Oy
PrivateLast Round
Grant
Jan 1, 2020
Total Funding Raised
$2.46M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ReBio Technologies Oy operates in Healthcare & Life Sciences and is based in Raisio. Its latest recorded funding round was a Grant round in January 2020.
ReBio Technologies Oy is a biotechnology company that develops targeted, vision-preserving therapies for ocular oncology and chronic eye diseases using its proprietary SiSu therapeutic amplifier technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReBio Technologies Oy Comparables
Compare ReBio Technologies Oy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ripple Therapeutics | 84% | |
| PolyActiva | 82% | |
| Re-Vana Therapeutics | 82% |
For institutional investors. Book with your work email.
ReBio Technologies Oy Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ReBio Technologies Oy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Seed, Grant |
| WI Harper Group | Seed |
| Kinled Holding | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 266% MoM, reaching 2K.
- Jun 20, 2026
Monthly visitors increased 110% MoM.
For institutional investors. Book with your work email.
ReBio Technologies Oy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReBio Technologies Oy's valuation, stock price, and market status.
Is ReBio Technologies Oy a public or private company?
ReBio Technologies Oy is a private company.
What is the current stock price of ReBio Technologies Oy?
ReBio Technologies Oy is a private company, so its shares have no public market price. Caplight tracks ReBio Technologies Oy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReBio Technologies Oy worth (valuation)?
Valuation information for ReBio Technologies Oy is not publicly available.
Can I buy ReBio Technologies Oy stock?
ReBio Technologies Oy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReBio Technologies Oy's last funding round?
ReBio Technologies Oy's most recent funding round was Grant on January 1, 2020.
Who are the main investors in ReBio Technologies Oy?
Key investors in ReBio Technologies Oy include Business Finland, WI Harper Group, Kinled Holding.
Will ReBio Technologies Oy IPO soon?
No public IPO plans have been announced for ReBio Technologies Oy.
How can I track ReBio Technologies Oy secondary market activity?
Caplight tracks bids, offers, and trades in ReBio Technologies Oy's shares on secondary markets.